PharmiWeb.com - Global Pharma News & Resources
16-Mar-2022

Surgery-Associated Bacterial Infection to Boost Demand for Carbapenem-Based Antibiotics – Fact.MR Survey

250 Pages Carbapenem-based Antibiotics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Carbapenem-based Antibiotics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Carbapenem-based Antibiotics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4425

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Carbapenem-based Antibiotics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Carbapenem-based Antibiotics

The report offers actionable and valuable market insights of Carbapenem-based Antibiotics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Carbapenem-based Antibiotics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Carbapenem-based Antibiotics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Carbapenem-based Antibiotics Market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4425

Key Segments of Carbapenem-based Antibiotics Market

Fact.MR’s study on the carbapenem-based antibiotics therapy market offers information divided into four important segments – product, indication, sales channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Product Type
  • Meropenem
  • Ertapenem
  • Imipenem
  • Doripenem
  • Panipenem
  • Tebipenem
Indication
  • Intra-abdominal Infections
  • Urinary Tract Infections
  • Pneumonia
  • Bacterial Meningitis
  • Skin and Skin Structure Infections
  • Acute Pelvic Infections
  • Prophylaxis of Surgical Site Infection
  • Respiratory Tract Infections
  • Gynaecologic Infections
  • Endocarditis
  • Others
Sales Channel
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4425
 

Competitive Landscape

  • Pfizer Inc.
  • Merck Co. & Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.

are top players operating in the carbapenem-based antibiotics market. The top three players contributed more than 92% revenue share in the carbapenem-based antibiotics market in 2018.

Key players are prominently focusing on increasing their carbapenem-based antibiotics availability in different countries for the treatment of a large patient pool with bacterial infections.

Key Takeaways of Carbapenem-based Antibiotics Market Study

  • Larger patient pools and launch of novel products for the treatment of bacterial infections are expected to shape the carbapenem-based antibiotics market landscape.
  • Increasing prevalence of bacterial infections caused by longer stay in hospitals as well as immunocompromising chronic diseases that make patients prone to bacterial infections is expected to boost carbapenem-based antibiotics market growth.
  • Currently, the carbapenem-based antibiotics market is dominated by ertapenem. However, tebipenem is expected to gain traction during the forecast period in terms of revenue.
  • In terms of indication, pneumonia is expected to garner highest market share as compared to other bacterial infections owing to a large patient pool.

“ Recently, FDA granted Qualified Infectious Disease Product (QIDP) to sulopenem as well as tebipenem for new indications, which is further expected to broaden the growth prospect of the carbapenem-based antibiotics market,” says the Fact.MR Analyst.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Carbapenem-based Antibiotics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Carbapenem-based Antibiotics Historical volume analysis: The report provides a comparison of Carbapenem-based Antibiotics’s historical sales and projected sales performance for 2021-2031.
  • Carbapenem-based Antibiotics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Carbapenem-based Antibiotics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Carbapenem-based Antibiotics Consumption by demographics: The report investigates consumer behavior affecting Carbapenem-based Antibiotics demand outlook for the assessment period. Effect of their keenness for digital trends on Carbapenem-based Antibiotics market is carefully analyzed
  • Post COVID consumer spending on Carbapenem-based Antibiotics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Carbapenem-based Antibiotics market growth.

More Valuable Insights on Carbapenem-based Antibiotics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Carbapenem-based Antibiotics, Sales and Demand of Carbapenem-based Antibiotics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

The post Surgery-Associated Bacterial Infection to Boost Demand for Carbapenem-Based Antibiotics – Fact.MR Survey appeared first on Latest Market Reports.

Editor Details

Last Updated: 16-Mar-2022